Results 111 to 120 of about 20,957 (246)

Problems in the therapy of mixed malarial infections [PDF]

, 1993
Cook, Dixon, F.J. Hess, H.D. Nothdurft, H.D.A. Kilian, Nothdurft, T. Löscher, WHO   +7 more
core   +1 more source

Developing Ontology Support for Human Malaria Control Initiatives [PDF]

, 2011
Malaria is one of the most common infectious diseases and an enormous public health problem in Sub-Sahara Africa, Asia and parts of America. In this paper, we discuss the development of the Human Malaria Control Ontology (HMCO) which contains ...
Daramola, Olawande, Fatumo, S.
core  

Mefloquine prophylaxis

The Lancet, 1993
ter Kuile, F, Nosten, F, Luxemburger, C, White, N   +3 more
openaire   +1 more source

A reiterative method for calculating the early bactericidal activity of antituberculosis drugs.

, 2002
Studies of early bactericidal activity (EBA) are important in the rapid evaluation of new antituberculosis drugs. Historically, these have concentrated on the log fall in the viable count in sputum during the first 48 hours of therapy.
Charalambous, Bambos M, Gillespie, Stephen H, Gosling, Roland D   +2 more
core   +1 more source

Mefloquine Prophylaxis In Pregnancy [PDF]

, 1995
A. Clinton White, J. H. Runnels
openalex   +1 more source

The spread of antimalarial drug resistance: A mathematical model with practical implications for ACT drug policies [PDF]

, 2008
Most malaria-endemic countries are implementing a change in antimalarial drug policy to artemisinin combination therapy (ACT). The impact of different drug choices and implementation strategies is uncertain.
Arjen Dondorp, Ian Hastings, Nicholas Day, Nicholas White, Shunmay Yeung, Wirichada Pongtavornpinyo   +5 more
core   +1 more source

Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments [PDF]

, 2023
Daisuke Akazawa, Hirofumi Ohashi, Takayuki Hishiki, Takeshi Morita, Shoya Iwanami, Kwang Su Kim, Yong Dam Jeong, Eun‐Sil Park, Michiyo Kataoka, Kaho Shionoya, Junki Mifune, Kana Tsuchimoto, Shinjiro Ojima, Aa Haeruman Azam, Shogo Nakajima, Hyeongki Park, Tomoki Yoshikawa, Masayuki Shimojima, Kotaro Kiga, Shingo Iwami, Ken Maeda, Tadaki Suzuki, Hideki Ebihara, Yoshimasa Takahashi, Koichi Watashi   +24 more
openalex   +1 more source

A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosus

Therapeutics and Clinical Risk Management, 2018
Yuichi Ishikawa, Tadamichi Kasuya, Junichi Ishikawa, Michio Fujiwara, Yasuhiko Kita Department of Rheumatology, Yokohama Rosai Hospital, Kohoku-ku, Yokohama, Kanagawa, Japan Abstract: Progressive multifocal leukoencephalopathy (PML) is a central ...
Ishikawa Y, Kasuya T, Ishikawa J, Fujiwara M, Kita Y   +4 more
doaj  

The Evaluation of Mefloquine Drug Repurposing on Acute Myeloid Leukemia [PDF]

, 2018
The aim of this study is to observe cell proliferation, cell viability, apoptosis, and autophagy on acute myeloid leukemia (AML) cell lines, NB4 and U937, with the drug repurposing of mefloquine (MQ).
Corey, Seth, Garg, Bhavuk, Mehta, Hrishikesh, Phan, Jessica L.   +3 more
core   +1 more source

Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults [PDF]

, 2015
Siwalee Rattanapunya, Tim R. Cressey, Ronnatrai Rueangweerayut, Yardpiroon Tawon, Panida Kongjam, Kesara Na-Bangchang   +5 more
openalex   +1 more source